Cargando…

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases

The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV present in 21 pediatric and adult patients who were treated in France for a range of diseases that involve infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongwiwat, Wiyada, Fournier, Benjamin, Bassano, Irene, Bayoumy, Amr, Elgueta Karstegl, Claudio, Styles, Christine, Bridges, Ray, Lenoir, Christelle, BoutBoul, David, Moshous, Despina, Neven, Bénédicte, Kanda, Teru, Morgan, Rhys G., White, Robert E., Latour, Sylvain, Farrell, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215254/
https://www.ncbi.nlm.nih.gov/pubmed/35612313
http://dx.doi.org/10.1128/jvi.00394-22
_version_ 1784731171873095680
author Wongwiwat, Wiyada
Fournier, Benjamin
Bassano, Irene
Bayoumy, Amr
Elgueta Karstegl, Claudio
Styles, Christine
Bridges, Ray
Lenoir, Christelle
BoutBoul, David
Moshous, Despina
Neven, Bénédicte
Kanda, Teru
Morgan, Rhys G.
White, Robert E.
Latour, Sylvain
Farrell, Paul J.
author_facet Wongwiwat, Wiyada
Fournier, Benjamin
Bassano, Irene
Bayoumy, Amr
Elgueta Karstegl, Claudio
Styles, Christine
Bridges, Ray
Lenoir, Christelle
BoutBoul, David
Moshous, Despina
Neven, Bénédicte
Kanda, Teru
Morgan, Rhys G.
White, Robert E.
Latour, Sylvain
Farrell, Paul J.
author_sort Wongwiwat, Wiyada
collection PubMed
description The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV present in 21 pediatric and adult patients who were treated in France for a range of diseases that involve infection of T or NK cells. Of these 21 cases, 5 pediatric patients (21%) and 11 adult patients (52%) were of Caucasian origin. In about 30% of the cases, some of the EBV genomes contain a large deletion. The deletions are different in every patient but tend to cluster near the BART region of the viral genome. Detailed investigation of a family in which several members have persistent T or NK cell infection by EBV indicates that the virus genome deletions arise or are selected independently in each individual patient. Genome sequence polymorphisms in the EBV in these T or NK cell diseases reflect the geographic origin of the patient and not a distinct type of EBV (the 21 cases studied included examples of both type 1 and type 2 EBV infection). Using virus produced from type 1 or type 2 EBV genomes cloned in bacterial artificial chromosome (BAC) vectors, we demonstrate infection of T cells in cord blood from healthy donors. Our results are consistent with transient infection of some T cells being part of normal asymptomatic infection by EBV in young children. IMPORTANCE EBV contributes to several types of human cancer. Some cancers and nonmalignant lymphoproliferative diseases involving T or NK cells contain EBV. These diseases are relatively frequent in Japan and China and have been shown sometimes to have deletions in the EBV genome in the disease cells. We identify further examples of deletions within the EBV genome associated with T or NK cell diseases, and we provide evidence that the virus genomes with these deletions are most likely selected in the individual cases, rather than being transmitted between people during infection. We demonstrate EBV infection of cord blood T cells by highly characterized, cloned EBV genomes and suggest that transient infection of T cells may be part of normal asymptomatic infection by EBV in young children.
format Online
Article
Text
id pubmed-9215254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-92152542022-06-23 Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases Wongwiwat, Wiyada Fournier, Benjamin Bassano, Irene Bayoumy, Amr Elgueta Karstegl, Claudio Styles, Christine Bridges, Ray Lenoir, Christelle BoutBoul, David Moshous, Despina Neven, Bénédicte Kanda, Teru Morgan, Rhys G. White, Robert E. Latour, Sylvain Farrell, Paul J. J Virol Virus-Cell Interactions The main target cells for Epstein-Barr virus (EBV) infection and persistence are B lymphocytes, although T and NK cells can also become infected. In this paper, we characterize the EBV present in 21 pediatric and adult patients who were treated in France for a range of diseases that involve infection of T or NK cells. Of these 21 cases, 5 pediatric patients (21%) and 11 adult patients (52%) were of Caucasian origin. In about 30% of the cases, some of the EBV genomes contain a large deletion. The deletions are different in every patient but tend to cluster near the BART region of the viral genome. Detailed investigation of a family in which several members have persistent T or NK cell infection by EBV indicates that the virus genome deletions arise or are selected independently in each individual patient. Genome sequence polymorphisms in the EBV in these T or NK cell diseases reflect the geographic origin of the patient and not a distinct type of EBV (the 21 cases studied included examples of both type 1 and type 2 EBV infection). Using virus produced from type 1 or type 2 EBV genomes cloned in bacterial artificial chromosome (BAC) vectors, we demonstrate infection of T cells in cord blood from healthy donors. Our results are consistent with transient infection of some T cells being part of normal asymptomatic infection by EBV in young children. IMPORTANCE EBV contributes to several types of human cancer. Some cancers and nonmalignant lymphoproliferative diseases involving T or NK cells contain EBV. These diseases are relatively frequent in Japan and China and have been shown sometimes to have deletions in the EBV genome in the disease cells. We identify further examples of deletions within the EBV genome associated with T or NK cell diseases, and we provide evidence that the virus genomes with these deletions are most likely selected in the individual cases, rather than being transmitted between people during infection. We demonstrate EBV infection of cord blood T cells by highly characterized, cloned EBV genomes and suggest that transient infection of T cells may be part of normal asymptomatic infection by EBV in young children. American Society for Microbiology 2022-05-25 /pmc/articles/PMC9215254/ /pubmed/35612313 http://dx.doi.org/10.1128/jvi.00394-22 Text en Copyright © 2022 Wongwiwat et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Virus-Cell Interactions
Wongwiwat, Wiyada
Fournier, Benjamin
Bassano, Irene
Bayoumy, Amr
Elgueta Karstegl, Claudio
Styles, Christine
Bridges, Ray
Lenoir, Christelle
BoutBoul, David
Moshous, Despina
Neven, Bénédicte
Kanda, Teru
Morgan, Rhys G.
White, Robert E.
Latour, Sylvain
Farrell, Paul J.
Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
title Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
title_full Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
title_fullStr Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
title_full_unstemmed Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
title_short Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
title_sort epstein-barr virus genome deletions in epstein-barr virus-positive t/nk cell lymphoproliferative diseases
topic Virus-Cell Interactions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215254/
https://www.ncbi.nlm.nih.gov/pubmed/35612313
http://dx.doi.org/10.1128/jvi.00394-22
work_keys_str_mv AT wongwiwatwiyada epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT fournierbenjamin epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT bassanoirene epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT bayoumyamr epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT elguetakarsteglclaudio epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT styleschristine epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT bridgesray epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT lenoirchristelle epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT boutbouldavid epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT moshousdespina epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT nevenbenedicte epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT kandateru epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT morganrhysg epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT whiteroberte epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT latoursylvain epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases
AT farrellpaulj epsteinbarrvirusgenomedeletionsinepsteinbarrviruspositivetnkcelllymphoproliferativediseases